Navigation Links
Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008
Date:3/23/2009

Other expense 1,946 1,622 4,494 2,802 Gain on early retirement of debt - (912) - (912) Stock compensation expense Included in general and administrative 890 337 3,555 1,953 Included in cost of services 47 59 191 140 Depreciation and amortization 15,255 18,611 57,297 71,786 Adjusted EBITDA $57,884 $76,492 $254,928 $270,287 Specialty hospitals $48,808 $68,771 $217,175 $236,388 Outpatient rehabilitation 15,167 17,031 75,437 77,279 Other (1) (6,091) (9,310) (37,684) (43,380) Adjusted EBITDA $57,884 $76,492 $254,928 $270,287 (1) Other primarily includes Select's general and administrative costs.

    The following tables reconcile specialty hospital
    same store information.

                                                  Three Months Ended
                                           December 31,      December 31,
                                               2007             2008
    Specialty hospitals net operating
     revenue                                 $352,877         $383,681
    Less: Specialty hospitals in
     development, opened or closed after
     1/1/07                                    12,348           29,264
    Specialty hospitals same store net
     operating revenue                       $340,529         $354,417

    Specialty hospitals Adjusted EBITDA       $48,808          $68,771
    Less: Specialty hospitals in
     development, opened or closed after
     1/1/07                                    (6,863)          (5,287)
    Specialty hospitals same store
     Adjusted EBITDA                          $55,671          $74,058

    All specialty hospitals A
'/>"/>
SOURCE Select Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
5. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
6. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
7. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
8. Harvard Researchers Select S.C. BlueCross for National Honor
9. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
10. Fry Construction Selected for High-Profile Medical Imaging Project
11. Meth Project Advertisements Selected for National Prevention Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 2Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 3Health News:Innovative Applications of Flow Cytometry Win U.S. and European Researchers Free Accuri C6 Flow Cytometer(R) Systems 4Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 2Health News:InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software 3Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 2Health News:Frost & Sullivan: E-Healthcare in Western Europe Presents a Significant Market Opportunity for Wireless Technologies 3Health News:REES Announces New Baltimore Office 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6
Breaking Medicine Technology:Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 37 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 17 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 27 Proven Steps 3A How to Defeat Stress Without Going Through the Embarrassment of Counseling 3A Proven Ways to Defeat Stress 49176 3iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 1iMedica Selected by NJ Physicians as Preferred EHR Vendor 49173 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 1Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 2Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 3Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 4Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 5Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 6Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 7Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 8Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 9Somanetics Reports Second Quarter Results and Extension of Exclusive Distribution Agreement With Covidien 49170 10